Cardiopulmonary Stress Testing Systems Market Report 2026

Cardiopulmonary Stress Testing Systems Market Overview

• Cardiopulmonary Stress Testing Systems market size has reached to $5.75 billion in 2025 • Expected to grow to $7.53 billion in 2030 at a compound annual growth rate (CAGR) of 5.6% • Growth Driver: Cardiopulmonary Stress Testing Systems Meeting Growing Demand Amid Rising Cardiovascular Disease Rates • Market Trend: Artificial Intelligence–Enhanced Diagnostic Interpretation in Cardiopulmonary Stress Evaluation • North America was the largest region in 2025.

What Is Covered Under Cardiopulmonary Stress Testing Systems Market?

Cardiopulmonary stress testing systems are sophisticated diagnostic tools used in healthcare settings to evaluate the performance of the cardiovascular and respiratory systems under stress. These tests are valuable in designing individualized exercise prescriptions, assessing treatment effectiveness, and predicting prognosis in patients with cardiovascular and respiratory diseases. The main product types of cardiopulmonary stress testing systems are cardiopulmonary exercise testing (CPET) systems, stress ECG, pulse oximeters, single-photon emission computed tomography (SPECT), and stress blood pressure monitors. Cardiopulmonary exercise testing (CPET) systems refer to a type of product used to evaluate the overall efficiency of a patient's cardiovascular and pulmonary systems. These are used in various applications such as oxygen uptake, carbon dioxide, minute ventilation, and anaerobic thresholds and also by various end users such as hospitals, specialty clinics/cardiology clinics, ambulatory surgical centers, and diagnostic centers.

What Is The Cardiopulmonary Stress Testing Systems Market Growth Forecast?

The cardiopulmonary stress testing systems market size is expected to see strong growth in the next few years. It will grow to $7.53 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to increasing demand for personalized cardiac assessment, rising adoption of ai-based diagnostic analytics, expansion of preventive cardiology programs, growing integration of wearable monitoring technologies, increasing focus on outcome-based healthcare. Major trends in the forecast period include increasing adoption of integrated cpet systems, rising use of digital stress ecg platforms, growing deployment of advanced respiratory monitoring tools, expansion of data-driven exercise testing protocols, enhanced focus on predictive cardiac diagnostics.

What Is The Driver Of The Cardiopulmonary Stress Testing Systems Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the cardiopulmonary stress testing systems market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels. The reasons for increasing prevalence of cardiovascular diseases include unhealthy diet, physical inactivity, and urbanization. Cardiopulmonary stress testing systems assess cardiovascular health by evaluating cardiac and pulmonary function during exercise. It provides valuable information for prescribing individualized exercise programs tailored to a patient's functional capacity and cardiovascular limitations. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency of the United States, in 2023, cardiovascular disease caused 919,032 deaths, accounting for roughly one out of every three lives lost. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the cardiopulmonary stress testing systems industry.

Key Players In The Global Cardiopulmonary Stress Testing Systems Market

Major companies operating in the cardiopulmonary stress testing systems market are General Electric, Siemens Healthineers AG, Koninklijke Philips N.V., Masimo Corporation, Nihon Kohden Corporation, Welch Allyn, Fukuda Denshi Co Ltd, Spacelabs Healthcare, Schiller AG, Vyaire Medical Inc, Nonin Medical Inc, MGC Diagnostic Corporation, SunTech Medical Inc, COSMED srl, Allengers Medical Systems Ltd, Nasiff Associates Inc, Clarity Medical, Medisoft srl, Ergometrics Inc, Cardiac Science Corporation, Cardiopulmonary Corporation

Global Cardiopulmonary Stress Testing Systems Market Trends and Insights

Major companies operating in the cardiopulmonary stress testing system market are focusing on integrating AI-enabled diagnostic enhancements, such as intelligent metabolic analyzers that automate real-time interpretation of exercise-induced respiratory and cardiac data. Intelligent metabolic analyzers refer to advanced CPET devices that use embedded algorithms to analyze oxygen uptake, carbon dioxide production, heart-rate response, and ventilation efficiency during physical stress, helping clinicians obtain faster and more precise diagnostic insights. For instance, in 2023, COSMED S.r.l., an Italy-based medical diagnostics company, introduced the Q-NRG Max, a next-generation metabolic assessment system that offers automated data-analysis workflows, improved breath-by-breath gas-exchange accuracy, and a portable clinical design optimized for cardiopulmonary stress evaluations.

What Are Latest Mergers And Acquisitions In The Cardiopulmonary Stress Testing Systems Market?

In May 2024, WearLinq, a US-based health technology company that specializes in wearable devices for monitoring cardiac health, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. This strategic acquisition will enhance WearLinq’s ability to deliver comprehensive clinical services nationwide, expanding patient access to its eWave 6-lead wearable ECG monitor, which recently gained FDA 510(k) clearance. AMI Cardiac Monitoring is a US-based healthcare technology company that specializes in cardiac monitoring solutions.

What Defines the Cardiopulmonary Stress Testing Systems Market?

The cardiopulmonary stress testing systems market consists of sales of specialized systems, metabolic carts, and portable devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cardiopulmonary Stress Testing Systems Market Report 2026?

The cardiopulmonary stress testing systems market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiopulmonary stress testing systems industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.